Capital Fund Management (CFM)’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-73,702
Closed -$1.99M 2702
2025
Q2
$1.99M Buy
+73,702
New +$2.13M 0.01% 1684
2023
Q1
Sell
-31,141
Closed -$739K 1744
2022
Q4
$739K Sell
31,141
-41,921
-57% -$974K 0.01% 1194
2022
Q3
$1.21M Buy
73,062
+30,144
+70% +$678K 0.01% 1026
2022
Q2
$854K Buy
+42,918
New +$867K 0.01% 1126
2021
Q2
Sell
-10,095
Closed -$543K 1667
2021
Q1
$543K Buy
+10,095
New +$581K 0.01% 1120

Other funds holding VCYT

Capital Fund Management (CFM)'s VCYT Position: Q3 2025 in Review

Capital Fund Management (CFM) sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 73,702 shares — an estimated $1.99M sold.

Capital Fund Management (CFM) first reported a position in VCYT in Q1 2021 and held it in 5 quarters. The position peaked at $1.99M in Q2 2025. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Capital Fund Management (CFM) reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 73,702 Veracyte shares in Q3 2025, an estimated $1.99M.
  • Capital Fund Management (CFM) first reported a position in Veracyte in Q1 2021 and held it in 5 quarters.
  • Capital Fund Management (CFM)'s Veracyte position peaked at $1.99M in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.